Related references
Note: Only part of the references are listed.Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease
John M. Dye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Immune Parameters Correlate with Protection Against Ebola Virus Infection in Rodents and Nonhuman Primates
Gary Wong et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoprotein
Amy B. Papaneri et al.
VACCINE (2012)
A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence
Amy B. Papaneri et al.
VIROLOGY (2012)
Filovirus vaccines
Steven B. Bradfute et al.
HUMAN VACCINES (2011)
Inactivated or Live-Attenuated Bivalent Vaccines That Confer Protection against Rabies and Ebola Viruses
Joseph E. Blaney et al.
JOURNAL OF VIROLOGY (2011)
CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates
Nancy J. Sullivan et al.
NATURE MEDICINE (2011)
Characterization of a Single-Cycle Rabies Virus-Based Vaccine Vector
Emily A. Gomme et al.
JOURNAL OF VIROLOGY (2010)
Prospects for immunisation against Marburg and Ebola viruses
Thomas W. Geisbert et al.
REVIEWS IN MEDICAL VIROLOGY (2010)
Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic
Alexander A. Bukreyev et al.
VIROLOGY (2010)
Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species
Lisa E. Hensley et al.
PLOS PATHOGENS (2010)
Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule
Nancy J. Sullivan et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Protection against lethal challenge by Ebola virus-like particles produced in insect cells
Yuliang Sun et al.
VIROLOGY (2009)
Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene
Jonathan Cenna et al.
VACCINE (2008)
Immune responses against persistent viral infections: Possible avenues for immunotherapeutic interventions
Shinichiro Fuse et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2008)
Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge
Kelly L. Warfield et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Ebola outbreak killed 5000 gorillas
Magdalena Bermejo et al.
SCIENCE (2006)
Rabies virus glycoprotein as a carrier for anthrax protective antigen
Mary Ellen Smith et al.
VIROLOGY (2006)
Wild animal mortality monitoring and human Ebola outbreaks, Gabon and Republic of Congo, 2001-2003
P Rouquet et al.
EMERGING INFECTIOUS DISEASES (2005)
Strong cellular and humoral anti-HIV Env immune responses induced by a heterologous rhabdoviral prime-boost approach
GS Tan et al.
VIROLOGY (2005)
Multiple Ebola virus transmission events and rapid decline of central African wildlife
EM Leroy et al.
SCIENCE (2004)
Pathogenesis of filoviral haemorrhagic fevers
S Mahanty et al.
LANCET INFECTIOUS DISEASES (2004)
Immunogenicity study of glycoprotein-deficient rabies virus expressing simian/human immunodeficiency virus SHIV89.6P envelope in a Rhesus macaque
PM McKenna et al.
JOURNAL OF VIROLOGY (2004)
Functional human immunodeficiency virus type 1 (HIV-1) gag-pol or HIV-1 Gag-Pol and Env expressed from a single rhabdovirus-based vaccine vector genome
JP McGettigan et al.
JOURNAL OF VIROLOGY (2003)
Antibody-dependent enhancement of Ebola virus infection
A Takada et al.
JOURNAL OF VIROLOGY (2003)
Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 Gag have greatly reduced pathogenicity but are highly immunogenic
JP McGettigan et al.
JOURNAL OF VIROLOGY (2003)
Safety studies of the oral rabies vaccine SAD B19 in striped skunk (Mephitis mephitis)
A Vos et al.
JOURNAL OF WILDLIFE DISEASES (2002)
Development of a bait and baiting system for delivery of oral rabies vaccine to free-ranging African wild dogs (Lycaon pictus)
DL Knobel et al.
JOURNAL OF WILDLIFE DISEASES (2002)
Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines
CA Siler et al.
VIROLOGY (2002)
Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector
JP McGettigan et al.
JOURNAL OF VIROLOGY (2001)
Rabies virus-based vectors expressing human immunodeficiency virus type 1 (HIV-1) envelope protein induce a strong, cross-reactive cytotoxic T-lymphocyte response against envelope proteins from different HIV-1 isolates
JP McGettigan et al.
JOURNAL OF VIROLOGY (2001)
Share Paper
